CREATIVE KINGDOMS, LLC v. ITC (Fed. Cir. 2014) (NP) – The specification must supply the novel aspects of an invention in order to constitute adequate enablement

Although a specification need not disclose what is well-known in the art, “[i]t is the specification, [and] not the knowledge of one skilled in the art, that must supply the novel aspects of an invention in order to constitute adequate enablement.” Here, for example,...

ANTARES PHARMA INC. v. MEDAC PHARMA INC. (Fed. Cir. 2014) (P) – Specification must “clearly and unequivocally” disclose invention claimed on reissue as a separate invention

The “original patent” requirement is a heightened standard compared to the separate written description requirement in that the specification must “clearly and unequivocally” disclose the particular invention claimed on reissue as a separate invention. Here, for...

SCRIPTPRO, LLC v. INNOVATION ASSOCIATES (Fed. Cir. 2014) (P) – Qualifiers such as “generally” or “broadly” may avoid inference that a list of features is essential

Although the inclusion of truly essential features may be required for a claim to satisfy the written description requirement, the court acknowledged that “[i]t is common, and often permissible, for particular claims to pick out a subset of the full range of described...

ABBVIE DEUTSCHLAND GMBH & CO. v. JANSSEN BIOTECH, INC. (Fed. Cir. 2014) (P) – Representative species must be diverse when relied upon to satisfy written description of broader genus

Absent any structural features common to the members of a claimed genus, the specification must disclose representative species that are diverse across the breadth of the claimed genus in order to satisfy the written description requirement. “[A]nalogizing the genus...